Clinical Trials Browser

Phase 1/2 × chiauranib × Clear all

NCT05271292 2024-07-16

SCLC

Phase 1/2 Recruiting

Small Cell Lung Carcinoma

NCT03974243 2022-03-09

Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma

Phase 1/2 Completed

Lymphoma, Non-Hodgkin

NCT03245190 2021-06-18

Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma

Phase 1/2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT03166891 2020-01-18

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

Phase 1/2 Completed

Ovarian Neoplasms, Recurrence